KR20090084117A - Cosmetic composition using shizonepetae herba and nelumbinis semen - Google Patents

Cosmetic composition using shizonepetae herba and nelumbinis semen Download PDF

Info

Publication number
KR20090084117A
KR20090084117A KR1020080010107A KR20080010107A KR20090084117A KR 20090084117 A KR20090084117 A KR 20090084117A KR 1020080010107 A KR1020080010107 A KR 1020080010107A KR 20080010107 A KR20080010107 A KR 20080010107A KR 20090084117 A KR20090084117 A KR 20090084117A
Authority
KR
South Korea
Prior art keywords
extract
activity
cosmetic composition
extracts
herba
Prior art date
Application number
KR1020080010107A
Other languages
Korean (ko)
Other versions
KR100949925B1 (en
Inventor
염교선
김종귀
윤태영
김영부
Original Assignee
주식회사 아이피어리스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아이피어리스 filed Critical 주식회사 아이피어리스
Priority to KR1020080010107A priority Critical patent/KR100949925B1/en
Publication of KR20090084117A publication Critical patent/KR20090084117A/en
Application granted granted Critical
Publication of KR100949925B1 publication Critical patent/KR100949925B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Abstract

A mixture herbal medicine composition as a cosmetic functional ingredient is provided to have anti-inflammation, antioxidation, whitening and antibacterial activity and improve skin condition without side effect. A cosmetic composition comprises extracts of Schizonepetae Herba and Nelumbinis Semen. The extracts of Schizonepetae Herba and Nelumbinis Semen is mixed in a same ratio. The extract is obtained by dipping the Schizonepetae Herba and Nelumbinis Semen in 70% ethanol. The extract further comprises Mulberry root-bark. The cosmetic composition is used in a form of toner, emulsion, serum, cream type, cleansing product, make-up or powder.

Description

형개, 연자육을 이용한 화장료 조성물{Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen}Cosmetic composition using hyunggae, soft meat {Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen}

본 발명은 항염, 항산화 및 미백, 항균 효과를 지닌 화장품 기능성 원료로서의 복합 한약재 조성물에 관한 것으로 형개, 연자육을 일정 비율로 추출하여 얻은 추출물은 항염, 항산화 및 미백, 항균의 우수한 활성을 나타내며 화장품 기능성 원료로 사용될 수 있다.The present invention relates to a composite herbal composition as a cosmetic functional raw material having an anti-inflammatory, antioxidant and whitening, antibacterial effect, the extract obtained by extracting a certain amount of hyeongjak, lotus root meat exhibits excellent activity of anti-inflammatory, antioxidant and whitening, antibacterial Can be used as

우리 인체는 외부 환경과 밀접하게 접하고 있고 환경 오염, 유해 물질, 스트레스, 불규칙한 생활 습관 등에 의해 쉽게 민감화 된다. 이러한 외부환경에 의해 노출된 피부는 활성 산소 즉, 프리라디칼이 발생되고 발생된 활성 산소와 프리라디칼은 정상적인 세포 조직이나 세포막을 공격하여 세포가 파괴되고 피부는 결국 염증을 일으키게 된다. 염증화된 조직은 피부의 생리학적 메카니즘에 의해 단백질이나 유전자 물질 등을 파괴하여 피부 트러블뿐만 아니라 아토피 피부염, 피부노화 등을 일으키는 주요 원인이 되고 있다. 또한 피부가 자외선에 과다 노출되면 티로시나제의 작용으로 멜라노좀에서 멜라닌 합성이 촉진되어 피부노화가 빠르게 진행 되고, 이때 생성된 프리라디칼이 지질, 단백질, 당 및 핵산을 손상시키고 세포막의 파괴에 관여함으로써 돌연변이를 유발시키고, 피부암을 발생시킨다.Our human body is in close contact with the external environment and is easily sensitized by environmental pollution, harmful substances, stress, and irregular lifestyles. The skin exposed by such an external environment generates free radicals, that is, free radicals, and the generated free radicals and free radicals attack normal cellular tissues or cell membranes, resulting in cell destruction and skin eventually causing inflammation. Inflammatory tissues are the main causes of skin problems as well as atopic dermatitis and skin aging by destroying proteins and genetic material by physiological mechanisms of the skin. In addition, when the skin is overexposed to ultraviolet rays, the action of tyrosinase promotes melanin synthesis in melanosomes, leading to rapid skin aging, and the resulting free radicals damage lipids, proteins, sugars and nucleic acids, and are involved in the destruction of cell membranes. Cause skin cancer.

이러한 피부상태의 문제점을 개선하기 위하여 우선적으로 주위 생활환경을 개선하는 것이 중요하지만, 부수적으로 기능을 상실한 피부를 정상화 시키기 위하여 다양한 방법이 필요하다. 이에 피부 상태를 개선하는데 도움을 주는 여러 가지의 생약재 성분들을 함유한 화장료가 개발되어 건강한 피부를 유지시키는데 이용되고 있다. 하지만 생약재가 함유된 화장료라도 효과가 정확하게 규명되지 않은 제품을 사용하는 것은 오히려 소비자들에게 악영향을 끼칠 수 있으므로 화장품에 적용하기 전에 이러한 생약재의 피부와 관련된 다양한 활성 검증이 필요하다. In order to improve the problems of the skin condition, it is important to improve the surrounding living environment first, but various methods are necessary to normalize the skin that has additionally lost its function. Therefore, cosmetics containing various herbal ingredients that help improve skin condition have been developed and used to maintain healthy skin. However, using cosmetics that contain herbal medicines that have not been accurately identified can adversely affect consumers, so it is necessary to verify the various activities related to the skin of these herbal medicines before applying them to cosmetics.

이에, 본 발명은 일상생활 중에서 접하기 쉬운 유해환경 즉 환경오염, 자외선, 유해물질, 스트레스, 불규칙적인 생활습관 등에 의한 피부 트러블 및 노화에 도움을 줄 수 있는 기능성 화장품의 원료 개발에 중점을 두었다. 피부 적용 시 부작용을 수반하지 않으면서도, 주변에서 쉽게 이용 가능하고, 피부 상태를 개선하는데 도움을 줄 수 있는 한약재, 특히 동의보감의 처방에 근거하여 생약재를 선정하였다. 또한 다양한 방법으로 추출한 후 화장품에 적용하기 적합한 추출법을 선택하였고, 추출물을 농도별로 조제하고 in vitro 항산화 및 항염, 항균, 미백활성을 측정하여 우수한 화장품 기능성 원료로서의 가능성을 검토하였다.Thus, the present invention focused on the development of raw materials of functional cosmetics that can help skin trouble and aging due to harmful environment, namely environmental pollution, ultraviolet rays, harmful substances, stress, irregular lifestyle, etc., which are easily encountered in daily life. Herbal medicines were selected based on the prescription of herbal medicines, especially Dongbobogam, which can be easily used around the skin and help improve skin condition without accompanying side effects. In addition, after extracting by various methods, suitable extraction methods for cosmetics were selected, and the extracts were prepared by concentration, and the in vitro antioxidant and anti-inflammatory, antibacterial and whitening activities were measured to examine the possibility of excellent cosmetic functional ingredients.

상기 본 발명의 목적은 형개, 연자육을 동일 비율로 혼합한 추출물에 의해 달성된다. The object of the present invention is achieved by an extract of the same ratio of hyeongjak, soft and soft.

본 발명은 형개, 연자육을 동일 비율로 혼합한 추출물은 항염, 항산화 및 미백, 항균활성을 나타낸다. In the present invention, the extracts of the same ratio of hyungjak and lotus roots are anti-inflammatory, antioxidant and whitening, antibacterial activity.

본 발명은 형개, 연자육을 동일 비율로 혼합한 추출물과 각 구성약재의 항염, 항산화 및 미백, 항균활성을 나타내는 화장료 조성물이다. The present invention is a cosmetic composition showing the anti-inflammatory, antioxidant and whitening, and antimicrobial activity of the extract and mixture of lotus root and lotus root in the same ratio.

여기에 흔히 미백화장료의 원료로 사용되는 상백피를 추가로 혼합한 혼합추출물을 사용할 수도 있다. Here, a mixed extract of an additional mixture of baekbaekpi, which is often used as a raw material for whitening cosmetics may be used.

본 발명에 사용된 형개 (Schizonepeta tenuifolia Briq.)는 꿀풀과 (Labiatae)에 속하는 1년생 초본으로 성질이 따뜻하고 맛이 매우면서 쓰며 독이 없다. 한방에서는 형개의 지상부를 감기의 발열, 인후 종통, 마진, 산후의 중풍 및 대하증 등의 치료제, 지혈제로 사용하여 왔으며 마우스에서 항혈소판 응집작용, 면역글로블린에 의한 생체 방어작용이 밝혀져 있다. 형개의 주요 성분으로는 flavonoid와 정유이며 flavonoid는 피부 염증 완화 및 진정작용이 우수하다. 정유는 d-menthone, l-pulegone을 주성분으로 하고, l-isomenthone, d-limonene, isopluegone, piperitenone 등의 monnterpene과 caryophyllene, β-clemene, β-humulene 등의 sesquiterpene, 3-octanone, 3-octanol, l-octun-3-ol 등으로 조성되어 있다. Mold opening used in the present invention ( Schizonepeta tenuifolia Briq.) is a herbaceous herb that belongs to Labiatae, warm in nature, tastes very bitter, and has no poison. In oriental medicine, the ground of the penis has been used as a treatment for cold fever, sore throat, margin, postpartum stroke and hypothalamus, and hemostatic agents. Antiplatelet aggregation and immunoglobulin bioprotective activity has been found in mice. Flavonoids and essential oils are the main components of the mold, and flavonoids are excellent for alleviating skin inflammation and sedating. Essential oils consist of d -menthone, l -pulegone, and sesquiterpene, 3-octanone, 3-octanol, such as monnterpene such as l -isomenthone, d -limonene, isopluegone, piperitenone, and caryophyllene, β-clemene, β-humulene, etc. l -octun-3-ol.

연자육은 수련과 (Nymphaeaceae)에 속하는 다년생 수생식물 연꽃 (Nelumbo mcifera Gaertner)의 성숙한 열매의 껍질 부분을 제거한 종자로서 맛은 달며, 성질은 평이하다. 연밥 혹은 연자로 불리우며 예부터 한방 및 민간에서 약재 혹은 식용으로 널리 사용되어 왔다. 연꽃은 사용부위에 따라 명칭을 달리하는데 잎은 하엽, 뿌리는 우절, 과방은 연방, 암술은 연수, 종자 안의 녹색 배아를 연자심이라 한다. 연자육은 한방에서 주로 지혈, 어혈제거, 해혈, 토혈, 혈뇨, 혈변을 치료하는데 사 용되고 있으며, 지사, 이뇨, 해열, 항균 및 항당뇨, 항산화 등의 효능이 있다. 연자육의 주요 성분으로는 nuciferine, N-nornuciferine, O-nornuciferine, roemerine 등의 aporphine계 alkaloid와 liensinine, isoliensinine, neferine 등의 phenolic alkaloid 및 (+)-1(R)-coclaurine, (-)-1(S)-norcoclaurine 등 benzylisoquinoline alkaloid 성분들이 있으며, 그밖에 (+)-catechin, (+)-gallocatechin, quercetin, kaempferol 등의 flavonoid 화합물 및 tryptophan, asparagine, tyrosine 등 amino acid 성분들이 있다. Lotus root is a seed removed from the bark of the mature fruit of the perennial aquatic plant lotus ( Nelumbo mcifera Gaertner) belonging to the Nymphaeaceae, tastes sweet and its nature is plain. It's called lotus or yeonjang, and it has been widely used in medicine and edible since ancient times. The name of the lotus is different depending on where it is used. The leaf is lower lobe, the root is falcon, the fruit is federal, the pistil is soft, and the green embryo in the seed is called soft core. Yeonjagi is mainly used to treat hemostasis, blood removal, haemostasis, hemostasis, hematuria, bloody stool in oriental medicine. The main components of lotus root meat are aporphine alkaloids such as nuciferine, N -nornuciferine, O -nornuciferine and roemerine, and phenolic alkaloids such as liensinine, isoliensinine and neferine and (+)-1 (R) -coclaurine, (-)-1 ( There are benzylisoquinoline alkaloids such as S) -norcoclaurine, and flavonoid compounds such as (+)-catechin, (+)-gallocatechin, quercetin and kaempferol and amino acid components such as tryptophan, asparagine and tyrosine.

상백피 (Mulberry root-bark, Mori Radicis Cortex)는 뽕나무 (Morus alba L.) 또는 그 밖의 동속식물 (뽕나무과 Moraceae)의 뿌리껍질로서 성질은 차고 맛은 달며 독이 없다. 해열, 항경련, 항알러지, 항염증 작용과 더불어 이뇨 촉진, 미백 등의 효과가 있으며 주요 생리활성 성분으로 morusin, cyclomorusin, sanggenon A~E, kuwanone A, B, C, α-amyrin, β-amyrin, 지방산 등을 함유하고 있다. Morus root-bark, Mori Radicis Cortex, Morus alba L.) or other related plants (Moraceae), the root bark, cold, sweet and nontoxic. Antipyretic, anticonvulsant, anti-allergic, anti-inflammatory, diuretic, whitening, etc. The main physiologically active ingredients are morusin, cyclomorusin, sanggenon A ~ E, kuwanone A, B, C, α-amyrin, β-amyrin , Fatty acids and the like.

본 발명에 사용된 상기의 생약재들은 일상생활에서 경험할 수 있는 여러 피부질환에 대하여 효능, 효과가 매우 우수하다고 여러 문헌들과 논문에 보고되어 있다. 이에 상기의 생약재들을 동의보감 등의 문헌에 근거하여 항염 및 항산화 효과를 다양한 in vitro 실험을 통해 확인할 수 있겠다. The herbal medicines used in the present invention have been reported in various literatures and articles that are very effective and effective against various skin diseases that can be experienced in everyday life. Therefore, the anti-inflammatory and antioxidant effects can be confirmed by various in vitro experiments based on the above herbal medicines.

본 발명에 사용된 생약재는 형개 : 연자육을 동량으로 혼합하여, 물과 에탄올 혼합액(30: 70, w/w)을 사용하여 24시간 실온에서 침지 추출하고 여과한 후 농축을 과정을 거쳐 최종 추출물을 얻었다. 비교 추출물도 같은 방법으로 하여 준비하였다. Herbal medicines used in the present invention is the type of hyeongjak: softly mixed with the same amount, immersion extraction at room temperature for 24 hours using water and ethanol mixture (30: 70, w / w), filtered and concentrated to the final extract Got it. Comparative extracts were also prepared in the same manner.

본 발명에서 상기의 생약재 추출물은 항염 및 항산화 효과를 특징으로 여러 화장료 조성물에 이용될 수 있다. The herbal extract of the present invention can be used in various cosmetic compositions characterized by anti-inflammatory and antioxidant effects.

상기의 생약재 추출물의 추출방법, 생약재 추출물의 in vitro 항산화 및 항염, 항균, 미백효과를 아래의 제조예, 실험예를 통하여 더욱 자세히 설명하였다. The extraction method of the herbal medicine extract, in vitro antioxidant and anti-inflammatory, antibacterial, whitening effect of the herbal medicine extract was described in more detail through the following preparation examples, experimental examples.

추출방법Extraction Method

추출물 1의 제조(Preparation of Extract 1 시험군Test group , , HYHY ):):

형개, 연자육을 각 15g을 분쇄 후 70% 에탄올 300㎖을 넣고 24시간 동안 상온에서 교반 추출하였다. 추출물은 여과 후 1/10로 농축하였다.After grinding 15g of each mold and soft porridge, 300ml of 70% ethanol was added and the mixture was stirred and extracted at room temperature for 24 hours. The extract was concentrated to 1/10 after filtration.

추출물 2의 제조 (Preparation of Extract 2 ( 시험군Test group , , HSHS ):):

형개, 연자육, 상백피 각 15g을 분쇄 후 70% 에탄올 450㎖을 넣고 24시간 동안 상온에서 교반 추출하였다. 추출물은 여과 후 1/10로 농축하였다.After grinding 15g of hyungpyeong, yeonjak, baekryepi each, and then put 450ml of 70% ethanol and extracted by stirring for 24 hours at room temperature. The extract was concentrated to 1/10 after filtration.

실험방법Experiment method

실험 1. Experiment 1. DPPHDPPH 에 의한 On by 자유라디칼Free radical 소거법에 따른 환원 활성 Reduction Activity by the Elimination Method

상기 생약재 추출물의 항산화 효과를 시험하기 위하여 전자공여능을 측정하여 대조군과 비교하였다. 전자공여능 측정에 사용된 1,1-디페닐-2-피크릴-히드라ㅓ질(DPPH, D9132, Sigma, USA)은 안정한 자유 라디칼로서, 만일 시료가 항산화 활성 을 갖고 있다면 DPPH가 갖고 있는 지질산화에 관여하는 자유 라디칼의 비공유결합을 소거하여 DPPH의 환원성을 높일 것이고, 보라색의 DPPH가 환원이 많이 될수록 보라색을 잃게 되어 UV 측정시 그 수치도 낮아진다. DPPH가 전자 또는 수소를 받으면 517nm부근에서 흡광도가 감소하며 각 추출물이 이러한 라디칼을 환원시키거나 상쇄시키는 능력이 크면 높은 항산화 활성 및 활성 산소를 비롯한 다른 라디칼에 대한 소거 활성을 기대할 수 있고, 인체 내에서 활성 라디칼에 의한 노화를 억제하는 척도로도 이용할 수 있다. DPPH를 0.2mM로 조제하여 DPPH 용액 1㎖에 농도별로 제조한 시료를 각각 첨가하였다. 실온에서 10분간 반응시킨 후 UV-가시광선 분광광도계(spectra plus384, molecular device, USA)로 517nm에서 흡광도를 측정하였다. 대조군은 시료액과 DPPH용액 대신 에탄올을 넣어 보정값을 얻었다. 자유 라디칼 소거율은 아래의 식에 따라 계산하였다. 결과는 도 1에 나타내었다. In order to test the antioxidant effect of the herbal extracts, the electron donating ability was measured and compared with the control group. The 1,1-diphenyl-2-picryl-hydrazil (DPPH, D9132, Sigma, USA) used in the measurement of electron donating ability is a stable free radical, and if the sample has antioxidant activity, the lipid oxidation of DPPH By eliminating the non-covalent bonds of free radicals involved in the DPPH will reduce the reducibility of DPPH, the more purple DPPH is reduced, the more purple is lost, the lower the value when measuring UV. When DPPH receives electrons or hydrogen, its absorbance decreases near 517 nm, and if each extract has a high ability to reduce or offset these radicals, high antioxidant activity and scavenging activity against other radicals including free radicals can be expected. It can also be used as a measure of suppressing aging by active radicals. DPPH was prepared at 0.2 mM, and samples prepared by concentration were added to 1 mL of DPPH solution. After reacting at room temperature for 10 minutes, the absorbance was measured at 517 nm with a UV-Vis spectrophotometer (spectra plus 384, molecular device, USA). For the control group, ethanol was added instead of the sample solution and the DPPH solution to obtain a correction value. Free radical scavenging rate was calculated according to the following formula. The results are shown in FIG.

소거율 (%) = (대조군의 흡광도-시험군의 흡광도) / 대조군의 흡광도 X 100% Clearance = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

대조군은 6-히드록시-2,5,6,8-테트라메틸크로만-2-카르복실산(Trolox, 97%, Aldrich, USA)를 사용하였다. 트롤록스는 비타민 E 유사체로 항산화 효능이 뛰어난 물질이다. 시험에서는 에탄올에 0.1% 농도로 희석한 후, 활성의 50%를 기준으로 하여 트롤록스와 비슷하거나 높은 값을 가지는 시료가 활성이 좋은 것으로 간주했다. 추출물 1은 추출물 2, 3보다 활성이 높으며 3가지 이상 복합재료를 사용하여도 활성이 증가하지 않음을 확인하였다. 추출물 1은 농도를 1/2, 1/5, 1/10로 희석하여 효과를 확인해 본 결과 활성의 차이는 없었다. 결과는 표 1에 나타내었다.The control group used 6-hydroxy-2,5,6,8-tetramethylchroman-2-carboxylic acid (Trolox, 97%, Aldrich, USA). Trolox is a vitamin E analogue that is highly antioxidant. In the test, samples diluted with 0.1% concentration in ethanol and having similar or higher values to trolox based on 50% of activity were considered to have good activity. Extract 1 was found to have higher activity than extracts 2 and 3, and activity was not increased even when three or more composite materials were used. Extract 1 was diluted in 1/2, 1/5, 1/10 concentration to confirm the effect, there was no difference in activity. The results are shown in Table 1.

표 1. 추출물 1 (Table 1. Extract 1 ( HYHY )의 )of 자유라디칼Free radical 소거 효과 (n=5) Elimination effect (n = 5)

농축액concentrate 1/21/2 1/51/5 1/101/10 트롤록스Trolox meanmean ±D(%)± D (%) 91.32±0.7991.32 ± 0.79 92.12±0.0292.12 ± 0.02 91.89±0.0291.89 ± 0.02 91.55±0.3691.55 ± 0.36 50.27±0.0350.27 ± 0.03

실험 2. Experiment 2. SODSOD 유사활성Pseudo-activity 측정 Measure

상기 생약재 추출물의 항산화 효과를 시험하기 위하여 전자공여능 뿐만 아니라 SOD 유사활성을 측정하여 생약재 추출물의 효과를 확인하였다. 활성산소 (reactive oxygen species) 소거활성 (SOD activity)은 크산틴/크산틴 옥시다제 (Sigma, USA) 효소반응에 의한 활성 산소 발생계를 이용하여 활성 산소에 의한 NBT (nitrobluetetrazolium, Sigma, USA)의 산화에 의한 흡광도 변화를 측정하여 평가하였다. 0.05mM Na2CO3 (Mw 105.99, Yakuri Pure Chemicals Co., Ltd, Japan) 2.4㎖, 3mM xanthine (X-0626, Sigma, USA) 0.1㎖, 3mM EDTA (E-5134, Sigma, USA) 0.1㎖, BSA (bovine serum albumin, A-7906, Sigma, USA) 0.1㎖, 0.75mM NBT (N-6875, Sigma, USA) 0.1㎖, 시료 0.1㎖를 넣고 잘 혼합한 후 25℃에서 10분간 정치하였다. 크산틴 옥시다제(X-4376, Sigma, USA) 0.1㎖를 넣고 25℃에서 20분간 반응시킨 후에 6mM CuCl2 (Daejung Chemicals & Metals Co., LTD, Korea) 0.1㎖를 넣어 반응을 정지시키고 UV-가시광선 분광광도계(spectra plus384, molecular device, USA)로 560nm에서 흡광도를 측정하였다. 대조군은 시료 대신 정제수를 넣으며, 크 산틴 옥시다아제 대신에 정제수를 넣어 색보정값을 얻었다다. 소거율은 DPPH 라디칼 소거율에 사용된 식에 따라 계산하였다. 결과는 도 2에 나타내었다.In order to test the antioxidant effect of the herbal extracts, the effects of the herbal extracts were determined by measuring the SOD-like activity as well as the electron donating ability. Reactive oxygen species SOD activity is determined by the activity of NBT (nitrobluetetrazolium, Sigma, USA) by reactive oxygen using a reactive oxygen generator by xanthine / xanthine oxidase (Sigma, USA) enzyme reaction. The absorbance change due to oxidation was measured and evaluated. 0.05 mM Na 2 CO 3 (Mw 105.99, Yakuri Pure Chemicals Co., Ltd, Japan) 2.4 ml, 3 mM xanthine (X-0626, Sigma, USA) 0.1 ml, 3 mM EDTA (E-5134, Sigma, USA) 0.1 ml , 0.1 ml of BSA (bovine serum albumin, A-7906, Sigma, USA), 0.1 ml of 0.75 mM NBT (N-6875, Sigma, USA), and 0.1 ml of sample were mixed well and allowed to stand at 25 ° C. for 10 minutes. 0.1 ml of xanthine oxidase (X-4376, Sigma, USA) was added and reacted at 25 ° C. for 20 minutes. Then, 0.1 ml of 6 mM CuCl 2 (Daejung Chemicals & Metals Co., LTD, Korea) was added to stop the reaction. Absorbance was measured at 560 nm with a visible light spectrophotometer (spectra plus 384, molecular device, USA). In the control group, purified water was added instead of the sample, and purified water was added instead of xanthine oxidase to obtain a color correction value. Scavenging rate was calculated according to the formula used for DPPH radical scavenging rate. The results are shown in FIG.

상기 생약재 추출물은 대조군인 비타민 C (L-아스코르빈산, A-1417, Sigma, USA)와 비교하여 항산화 효과를 확인하였다. 활성은 60 ~ 80%로 기준하였으며 이와 비슷하거나 높은 값을 가지는 경우 활성이 높은 것으로 간주했다. 추출물 1은 추출물 2, 3보다 활성이 높으며 실험1의 결과와 마찬가지로, 3가지 이상 복합재료를 사용하여도 활성이 증가하지 않음을 확인하였다. 또한 추출물 1은 농도감소 (1/2, 1/5, 1/10로 희석)에 상관없이 높은 활성을 가지고 있었다. 결과는 표 2에 나타내었다.The herbal extract was compared with the control vitamin C (L-ascorbic acid, A-1417, Sigma, USA) was confirmed the antioxidant effect. The activity was based on 60% to 80% and was considered to be high when the value was similar or high. Extract 1 has higher activity than extracts 2 and 3, and as in the result of Experiment 1, it was confirmed that the activity does not increase even when using three or more composite materials. In addition, extract 1 had high activity regardless of the concentration decrease (diluted by 1/2, 1/5, 1/10). The results are shown in Table 2.

표 2. 추출물 1 (Table 2. Extract 1 ( HYHY )의 )of SODSOD 유사 활성 (n=5) Pseudo-activity (n = 5)

농축액concentrate 1/21/2 1/51/5 1/101/10 비타민 CVitamin c meanmean ±D(%)± D (%) 96.24±0.8896.24 ± 0.88 97.33±0.3597.33 ± 0.35 92.67±0.5692.67 ± 0.56 98.67±0.7898.67 ± 0.78 60.94±0.2060.94 ± 0.20

실험 3. Experiment 3. 티로시나제Tyrosinase 저해 활성 시험( Inhibitory activity test ( InIn vitroin vitro tyrosinasetyrosinase inhibitioninhibition assayassay ))

상기 생약재 추출물의 미백 효과를 시험하기 위하여 티로시나제 저해 활성을 측정하여 대조군과 비교하였다. 피부는 자외선에 노출되면 티로시나제의 작용으로 멜라노좀에서 멜라닌이 합성되어 피부노화가 촉진되며, 티로시나제는 인체 내의 멜라닌 생합성 경로에서 가장 중요한 초기 속도 결정단계에 관여하는 효소로서 많은 미백 성분이 이 효소를 억제하는 작용 기전을 가지고 있다. 이 시험은 시료의 티로시나제 효소의 활성을 저해하는 정도를 평가하는 방법이다. 시료 0.9㎖, 0.1M 인산 염 완충액(pH 6.5) 1.0㎖, 1.5mM L-티로신(T8566, Sigma, USA) 1.0㎖을 넣은 후, 37℃에서 10분간 정치시켰다. 버섯 티로시나제(T3824, Sigma, USA) 0.1㎖를 첨가하여 37℃에서 10분간 반응시킨 후, UV-가시광선 분광광도계(spectra plus384, molecular device, USA)를 사용하여 480nm에서 흡광도를 측정하였다. 티로시나제 활성 저해율은 아래의 식에 따라 계산하였다. 결과는 도 3에 나타내었다.To test the whitening effect of the herbal extracts, tyrosinase inhibitory activity was measured and compared with the control group. When the skin is exposed to ultraviolet rays, the action of tyrosinase promotes skin aging by synthesizing melanin from melanosomes.Tyrosinase is an enzyme involved in the initial rate determining step of the melanin biosynthesis pathway in the human body. Has a mechanism of action. This test is a method of evaluating the degree of inhibition of tyrosinase enzyme activity in a sample. 0.9 ml of sample, 1.0 ml of 0.1 M phosphate buffer (pH 6.5) and 1.0 ml of 1.5 mM L-tyrosine (T8566, Sigma, USA) were added, and then allowed to stand at 37 ° C for 10 minutes. After 0.1 ml of mushroom tyrosinase (T3824, Sigma, USA) was added and reacted at 37 ° C. for 10 minutes, the absorbance was measured at 480 nm using a UV-Vis spectrophotometer (spectra plus384, molecular device, USA). The tyrosinase activity inhibition rate was calculated according to the following formula. The results are shown in FIG.

티로시나제 활성 저해율 (%) = ( 대조군의 흡광도-시험군의 흡광도 ) / 대조군의 흡광도 X 100% Inhibition of tyrosinase activity = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

미백활성을 평가하기 위해 대조군으로 2% 알부틴을 사용하여 활성을 비교하였다. 활성은 60 ~ 80%로 기준하였으며 이와 비슷하거나 높은 값을 가지는 경우 활성이 높은 것으로 간주하였다. 추출물 1은 농도감소 (1/2, 1/5, 1/10로 희석)에 상관없이 높은 활성을 가지고 있었다. 결과는 표 3에 나타내었다. To evaluate the whitening activity, the activity was compared using 2% arbutin as a control. The activity was based on 60% to 80% and was considered to be high when it had a similar or higher value. Extract 1 had high activity regardless of the concentration decrease (diluted to 1/2, 1/5, 1/10). The results are shown in Table 3.

표 3. 추출물 1(Table 3. Extract 1 ( HYHY )의 )of 티로시나제Tyrosinase 저해 활성 (n=5) Inhibitory activity (n = 5)

농축액concentrate 1/21/2 1/51/5 1/101/10 알부틴Arbutin meanmean ±D(%)± D (%) 89.88±0.8889.88 ± 0.88 82.25±0.35582.25 ± 0.355 87.00±0.0687.00 ± 0.06 86.88±0.4286.88 ± 0.42 73.63±0.5373.63 ± 0.53

실험 4. Experiment 4. 리폭시게나제Lipoxygenase (( LipoxigenaseLipoxigenase ) 활성 억제에 의한 항염시험Anti-inflammatory test by inhibition of activity

상기 추출물의 항염 효과를 평가하기 위하여 리폭시게나제 저해 활성을 측정 하였다. 지질의 과산화물 생성억제효과는 리놀레인산(L2376, Sigma, assay 98%, USA)를 기질로 사용하여 불포화 지방산의 산화과정에 따른 중간생성물질인 과산화물가를 측정하여 확인하였다. 리놀레인산 1㎖, 시료 0.1㎖, 리폭시게나제 (L7395, Sigma, USA) 0.9㎖를 시간, 속도를 일정하게 잘 혼합하여 25℃에서 10분간 반응시킨 후 20%w/v 트리클로로아세트산(TCA, Junsei Chemicals Co., Ltd, Japan) 0.5㎖, 0.6%w/v Thiobarbituric acid (TBA, T5500, Sigma, USA)를 넣어 혼합하여 끓는 물 속에서 10분간 가열하여 발색시킨 후 냉각시켰다. 냉각된 시료에 부탄올 2㎖를 넣고 20초간 보텍스교반기 (vortexmixer)로 혼합한 후 3,500rpm에서 5분간 원심분리하여 상층액을 얻었다. UV-가시광선 분광광도계(spectra plus384, molecular device, USA)를 사용하여 535nm에서 흡광도를 측정한다. 활성 저해율은 아래의 식에 따라 계산한다. 결과를 도 4에 나타내었다. In order to evaluate the anti-inflammatory effect of the extract, lipoxygenase inhibitory activity was measured. The inhibitory effect of lipid peroxide production was determined by measuring linoleic acid (L2376, Sigma, assay 98%, USA) as a substrate by measuring the peroxide value, an intermediate product of oxidation of unsaturated fatty acids. 1 ml of linoleic acid, 0.1 ml of sample, and 0.9 ml of lipoxygenase (L7395, Sigma, USA) were mixed well at a constant rate and time for 10 minutes at 25 ° C., followed by 20% w / v trichloroacetic acid (TCA , Junsei Chemicals Co., Ltd, Japan) 0.5ml, 0.6% w / v Thiobarbituric acid (TBA, T5500, Sigma, USA) was added and mixed by heating in boiling water for 10 minutes and then cooled. 2 mL of butanol was added to the cooled sample, mixed with a vortex mixer for 20 seconds, and centrifuged at 3,500 rpm for 5 minutes to obtain a supernatant. Absorbance is measured at 535 nm using a UV-Visible spectrophotometer (spectra plus 384, molecular device, USA). The activity inhibition rate is calculated according to the following formula. The results are shown in FIG.

리폭시게나제 활성 저해율 (%) = ( 대조군의 흡광도 -시험군의 흡광도 ) / 대조군의 흡광도 X 100% Inhibition of lipoxygenase activity = (absorbance of control group-absorbance of test group) / absorbance of control group X 100

본 추출물은 실험 1, 2, 3과는 달리 항염 활성에 대해서는 비교적 농도의존적이었다. 1/2 감소됨에 따라 활성이 28 % 정도 감소하였으며 농도를 10배 감소시켰더니 활성을 나타내지 않았다. 결과는 표 4에 나타내었다. Unlike the experiments 1, 2 and 3, the extract was relatively concentration dependent on anti-inflammatory activity. As the amount of 1/2 decreased, the activity decreased by 28% and the concentration was decreased by 10 times, indicating no activity. The results are shown in Table 4.

표 4. 추출물 1(Table 4. Extract 1 ( HYHY )의 항염 활성 (n=5)Anti-inflammatory activity of) (n = 5)

농축액concentrate 1/21/2 1/51/5 1/101/10 meanmean ±D(%) ± D (%) 63.09±0.9163.09 ± 0.91 45.43±2.0345.43 ± 2.03 42.89±0.1742.89 ± 0.17

실험 5 디스크 확산 (Experiment 5 Disc Diffusion ( DiscDisc diffusiondiffusion )법에 의한 항균력 측정 Antibacterial activity

상기 추출물의 항균활성은 디스크 확산 (Disc diffusion)법으로 측정하였다. 균주로 그람 양성균인 Staphylococcus aureus KCTC 3881, 그람 음성균으로 Pseudomonas aeruginosa KCTC 1750, 효모로 Candida albicans KCTC 7965, 곰팡이로 Aspergillus niger KCTC 6196를 실험에 사용하였다. 즉, 평판 배지에 배양된 각 균주를 1백금이 취해 액체 배지 10㎖에서 18~24시간 배양하여 활성화시킨 후 다시 액체 배지에 균액 0.1㎖를 접종하여 3~6시간 배양하였다. 이 균액을 평판배지 1개당 약 106~107 cells 되도록 saline에 접종한 후 멸균 면봉으로 균일하게 도말하였다. 멸균된 페이퍼 디스크를 고체 평판배지에 올려놓은 다음 0.05㎖/disc가 되도록 시료를 농도별로 흡수시켜 박테리아는 37℃에서 24시간, 효모는 25℃에서 48시간, 곰팡이는 25?에서 72시간 배양하여 디스크 주변의 clear zone을 확인하였다. 결과를 도 5 나타내었다. 실험 결과 효모 및 곰팡이에 대한 항균활성을 나타내지 않았으며 박테리아인 Staphylococcus aureus, Pseudomonas aeruginosa에 대해 뚜렷한 clear zone을 나타내어 항균활성을 확인할 수 있었다. The antimicrobial activity of the extract was measured by Disc diffusion method. Gram-positive strain Staphylococcus aureus KCTC 3881, Pseudomonas as Gram-negative bacteria aeruginosa KCTC 1750, Candida albicans as yeast KCTC 7965, Aspergillus as fungus niger KCTC 6196 was used for the experiment. In other words, each strain cultured in a plate medium was incubated with platinum and cultured in 10 ml of liquid medium for 18 to 24 hours to activate, and then inoculated with 0.1 ml of bacterial solution in the liquid medium and incubated for 3 to 6 hours. The fungus solution was inoculated in saline to about 10 6 to 10 7 cells per plate medium and evenly spread with a sterile swab. Place the sterilized paper disc on a solid plate medium and absorb the sample by concentration to 0.05ml / disc. Incubate the bacteria at 37 ℃ for 24 hours, yeast at 25 ℃ for 48 hours, and mold at 25? For 72 hours. The surrounding clear zone was confirmed. The results are shown in FIG. 5. Experimental results showed no antimicrobial activity against yeasts and molds and bacteria Staphylococcus aureus , Pseudomonas Antimicrobial activity was confirmed by showing clear clear zone against aeruginosa .

In vitro 실험결과, 구성약재 중 형개와 연자육 (HY)만 가지고도 항산화, 미 백, 항염, 항균의 모든 활성을 나타낼 수 있으며, 상백피를 추가하여 사용할 수도 있으나 상백피를 추가하여도 현저한 효능의 향상은 발견되지 않았다. 따라서, 형개와 연자육을 포함한 추출물은 화장품 원료로 적용할 수 있다.As a result of in vitro experiments, it is possible to show all the activities of antioxidant, whitening, anti-inflammatory, and antimicrobial even with only hyungjeo and yeonjak (HY) among the constituents. Not found. Therefore, extracts including mold opening and lotus root meat can be applied as a cosmetic raw material.

상기 약재는 자유라디칼 소거효과 및 활성산소 소거효과를 가져 항노화, 항산화에 효과를 나타낼 수 있으며 티로시나제 저해활성을 가지고 있어서 미백재료로 사용될 수도 있다. 또한 항염활성과 항균활성을 토대로 피부 트러블 개선 제품에도 첨가될 수 있으며 이런 기능을 복합적으로 나타내는 제품에도 적용할 수 있다. The medicine has free radical scavenging effect and free radical scavenging effect and can show effects on anti-aging and anti-oxidation. It can also be added to skin trouble improvement products on the basis of anti-inflammatory and antimicrobial activity and can be applied to products that combine these functions.

도 1은 본 발명의 생약재 추출물의 자유라디칼 소거효과를 나타낸 그래프1 is a graph showing the free radical scavenging effect of the herbal extract of the present invention

도 2는 본 발명의 생약재 추출물의 SOD 유사활성을 나타낸 그래프Figure 2 is a graph showing the SOD-like activity of the herbal extract of the present invention

도 3은 본 발명의 생약재 추출물의 티로시나제 저해활성을 나타낸 그래프Figure 3 is a graph showing the tyrosinase inhibitory activity of the herbal extract of the present invention

도 4는 본 발명의 생약재 추출물의 리폭시게나제 저해활성을 나타낸 그래프Figure 4 is a graph showing the lipoxygenase inhibitory activity of the herbal extract of the present invention

도 5는 본 발명의 생약재 추출물의 항균활성을 나타낸 사진Figure 5 is a photograph showing the antimicrobial activity of the herbal medicine extract of the present invention

Claims (6)

형개 및 연자육 추출물을 함유한 화장료 조성물.Cosmetic composition containing the extract of Hyeonggae and lotus root meat. 제 1항에 있어서, 형개 및 연자육 추출물은 동일한 중량비로 혼합된 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the mold extract and lotus root extract are mixed in the same weight ratio. 제 1항 또는 제 2항에 있어서, 상기 추출물은 형개 및 연자육을 70% 에탄올 (물 : 에탄올 = 3 : 7, w/w)에 침지하여 얻은 추출물인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1 or 2, wherein the extract is an extract obtained by immersing the open and soft muscles in 70% ethanol (water: ethanol = 3: 7, w / w). 제 1항에 있어서, 상기 추출물은 상백피를 더 포함하는 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the extract further comprises lettuce. 제 4항에 있어서, 상백피, 형개 및 연자육 추출물은 동일한 중량비로 혼합된 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 4, wherein the extracts of Morus alba L., H. C. and Yeonja meat are mixed in the same weight ratio. 제 1항에 있어서, 상기 화장료 조성물은 토너, 에멀젼, 세럼, 크림, 클렌징류, 메이크업 또는 파우더의 제형을 갖는 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition has a formulation of toner, emulsion, serum, cream, cleansing agent, makeup or powder.
KR1020080010107A 2008-01-31 2008-01-31 Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen KR100949925B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080010107A KR100949925B1 (en) 2008-01-31 2008-01-31 Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080010107A KR100949925B1 (en) 2008-01-31 2008-01-31 Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen

Publications (2)

Publication Number Publication Date
KR20090084117A true KR20090084117A (en) 2009-08-05
KR100949925B1 KR100949925B1 (en) 2010-03-30

Family

ID=41204724

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080010107A KR100949925B1 (en) 2008-01-31 2008-01-31 Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen

Country Status (1)

Country Link
KR (1) KR100949925B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101068976B1 (en) * 2011-02-24 2011-09-29 주식회사 사임당화장품 Manufacturing method of nelumbinis semen extract with alpha-glucosidase inhibitory effect and cosmetic composition comprising the extract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920002109A (en) * 1990-07-05 1992-02-28 김만경 Whitening cosmetics and cosmetics containing them
KR970021273A (en) * 1995-10-25 1997-05-28 성재갑 Whitening soap composition
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101068976B1 (en) * 2011-02-24 2011-09-29 주식회사 사임당화장품 Manufacturing method of nelumbinis semen extract with alpha-glucosidase inhibitory effect and cosmetic composition comprising the extract

Also Published As

Publication number Publication date
KR100949925B1 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
Lee et al. Antioxidant activity of extracts from Alpinia katsumadai seed
KR101936294B1 (en) Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata
KR102016027B1 (en) Cosmetics composition improving skin wrinkle and skin elasticity and cosmetics including the same
CN112493480B (en) Antioxidant composition and application thereof
KR102010404B1 (en) Cosmetics composition having improvement effect of skin reproduction and cosmetics including the same
KR20120140141A (en) Cosmetic composition comprising the fermented extracts and the extracts of the rice
KR100949926B1 (en) Funetional cosmetic composition containing herb medicine extract, having antiphlogistic, antioxidantal, whitening and anti-microbial effect
KR20140021315A (en) Cosmetic compositon for skin-irritation alleviation with inula britannica var. chinensis, cynanchi radix and lysimachia foenum-graecum hance
KR20130079220A (en) Skin external composition containing extract of soybean root
KR101787289B1 (en) Compositions having inhibitory effect on induction of grey hair and positive effect on induction of black hair
KR20190074663A (en) Natural soap composition
KR20100121352A (en) A composition comprising complex crude drug extract for anti-aging and improvement of skin
KR100949925B1 (en) Cosmetic composition using Shizonepetae Herba and Nelumbinis Semen
KR100898307B1 (en) Cosmetic composition with the antioxidant effect protecting skins aging
KR102611916B1 (en) Composition for skin improvement comprising multiple extract
KR102612017B1 (en) Composition for skin improvement comprising multiple extract
KR20080028029A (en) Cosmetic compositions comprising paulownia coreana uyeki leaf extract
KR101176526B1 (en) Cosmetic Composition Comprising the extract of Spiraea prunifolia var.simpliciflora as Active Ingredient
KR100604244B1 (en) Cosmetic composition containing Solanum Lycopersicum MILL.Extract
KR20170136912A (en) Composition for improving skin condition comprising herb extracts mixture
KR102364428B1 (en) Cosmetic composition containing fermented grain extract having high antioxidative activity
KR20180053930A (en) Honeyberry extract with increased antioxidant and antiobesity activity, manufacturing method thereof
KR102444462B1 (en) Composition having antioxidant and skin whitening effect and its use
KR20180026974A (en) cosmetic composition containing oriental medicinal herbs for reducing inflammation
KR20100110990A (en) A cosmetic composition comprising an extract of gymnema sylvestre and a preparing method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130201

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140228

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20160321

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20170322

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20180321

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20190311

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20200225

Year of fee payment: 11